LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 211 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,182 | -14.7% | 16,171 | -16.6% | 0.09% | -3.3% |
| Q4 2023 | $1,385 | +4.7% | 19,397 | -12.2% | 0.09% | +3.4% |
| Q3 2023 | $1,323 | +50.0% | 22,082 | +80.5% | 0.09% | +51.7% |
| Q2 2023 | $882 | +42.7% | 12,237 | +45.7% | 0.06% | +20.8% |
| Q1 2023 | $618 | -99.9% | 8,400 | +147.1% | 0.05% | -61.6% |
| Q3 2018 | $933,000 | +32.5% | 3,400 | 0.0% | 0.12% | +17.9% |
| Q2 2018 | $704,000 | +25.3% | 3,400 | 0.0% | 0.11% | +19.1% |
| Q1 2018 | $562,000 | – | 3,400 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |